Headquartered near Basel, Switzerland - a European biotech hub - Idorsia has a highly experienced team of dedicated professionals, covering all disciplines from bench to bedside; QUVIVIQ(TM) (daridorexant), a different kind of insomnia treatment with the potential to revolutionize this mounting public health concern; strong partners to maximize the value of our portfolio; a promising in-house development pipeline; and a specialized drug discovery engine focused on small-molecule drugs that can change the treatment paradigm for many patients. Idorsia is listed on the SIX Swiss Exchange (ticker symbol: IDIA).
The Head of Commercial EU & International is responsible for driving the commercial strategy, execution, and performance across all EU & International (EU&I) markets. The role acts as the senior commercial leader for the region, partnering closely with the President EU&I to achieve strong business results, ensure aligned strategic direction, and unlock the full potential of Idorsia's portfolio.
This position provides strategic leadership for QUVIVIQ across the region, co-leads lifecycle efforts in close collaboration with the US commercial organization, and plays a central role in shaping future pipeline development from a commercial perspective, starting with JERAYGO, first dual endothelin receptor antagonist approved in resistant hypertension in EU, UK, CH. The role also oversees regional business operations, insights, commercial capability building, and budget ownership for all regional commercial activities.
MNCJobs.ch will not be responsible for any payment made to a third-party. All Terms of Use are applicable.